Ex parte TS'O et al. - Page 4




          Appeal No. 1995-3147                                                        
          Application No. 07/946,023                                                  


          under 35 U.S.C. § 101 as based on a lack of demonstrated                    
          utility                                                                     
          that the claimed method and composition are effective for the               
          treatment of "viral diseases"; (4) claims 32, 36, and 37 under              
          35 U.S.C. § 103 as unpatentable over Ts'o in combination with               
          Munk and Chain or Ishida; and (5) claims 31 and 38 under                    
          35 U.S.C. § 103 as unpatentable over the combined disclosures               
          of Ts'o, Munk, Chain, Ishida, The Merck Index, and Bernstein.               
               On consideration of the record, including the Appeal                   
          Brief, the Examiner's Answer, and the Aurelian Declaration                  
          executed May 7, 1992, and attachments thereto, we find that                 
          the examiner's rejections lack merit.                                       
               Accordingly, it is ORDERED that the rejection of claims                
          37 and 38 under 35 U.S.C. § 112, first paragraph; the                       
          rejection of claims 31 and 38 under 35 U.S.C. § 112, first                  
          paragraph; the rejection of claims 37 and 38 under 35 U.S.C.                
          § 101; the rejection of claims 32, 36 and 37 under 35 U.S.C.                
          § 103 as unpatentable over Ts'o in combination with Munk and                
          Chain or Ishida; and the rejection of claims 31 and 38 under                
          35 U.S.C. § 103 as unpatentable over the combined disclosures               
          of                                                                          
                                         -4-                                          





Page:  Previous  1  2  3  4  5  6  Next 

Last modified: November 3, 2007